Substance / Medication

Cefazolin sodium

Overview

Clinical overview including description, indications, and evidence base is pending physician authorship or FDA SPL integration. Graph-derived relationship data is available below.

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Research Evidence

Published studies and systematic reviews

Sort:
Cefazolin sodium pentahydrate cause urolithiasis: a case report and literature review.
Wang Fujun, Nie Wen, Wang Zongjun et al. · J Surg Case Rep · 2022
PMID: 35422990Case ReportFull text (PMC)
Infection management in a patient with a left ventricular assist device: a case report of long-term cefazolin sodium hydrate administration.
Tayama Eiki, Arinaga Koichi, Shojima Takahiro et al. · J Artif Organs · 2006
PMID: 16807815Case Report
FeSnanosheets-luminol-Ochemiluminescence method for determination of venlafaxine hydrochloride, imipramine hydrochloride, and cefazolin sodium.
Iranifam Mortaza, Royan Maryam, Golshani Pariya et al. · Luminescence · 2024
PMID: 38644416Other
Cefazolin sodium pentahydrate combined with vacuum sealing drainage in the treatment of open fracture complicated with soft tissue injury.
Lou Wenjie, Zou Kai, Yu Zhongbin et al. · Rev Assoc Med Bras (1992) · 2020
PMID: 32578775Other
Quantitative analysis of cefazolin sodium in lyophilized powder by infrared spectrophotometry: Green, low cost, fast and effective.
Rechelo Bárbara Saú, Kogawa Ana Carolina, Salgado Hérida Regina Nunes · Spectrochim Acta A Mol Biomol Spectrosc · 2019
PMID: 30312842Other
High tolerance of and removal of cefazolin sodium in single-chamber microbial fuel cells operation.
Zhang Enren, Yu Qingling, Zhai Wenjing et al. · Bioresour Technol · 2018
PMID: 29040863Other

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Cefazolin sodium (substance)
SNOMED CT
80972005
UMLS CUI
C0700526

Clinical Data

This intervention maps to 11 entities in the Ltrl knowledge graph.

11
Conditions
0
Biomarkers
0
Specialists
0
Symptoms

Data is sourced from SNOMED CT, UMLS, and the Ltrl clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.